Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation
In this study, PTCy combined with additional immunosuppression after MUD/mMUD HSCT showed a reduction of aGVHD rate with safety results comparable to those obtained with the ATG-based prophylaxis.
Source: Annals of Hematology - Category: Hematology Source Type: research
More News: Hematology | Spain Health | Statistics | Stem Cell Therapy | Stem Cells | Study | Transplants